These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33972378)

  • 21. Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients.
    Mansouri E; Blome-Eberwein S; Gabelsberger J; Germann G; von Specht BU
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):161-6. PubMed ID: 12832120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Construction of MyD88-Pseudomonas aeruginosa epitope DNA vaccine and its expression in eukaryotic cells].
    Chen JG; Su ZL; Liu YZ; Wang SJ; Liu XX; Shao QX; Xu HX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Mar; 25(3):193-5. PubMed ID: 19257978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors affecting the folding of Pseudomonas aeruginosa OprF porin into the one-domain open conformer.
    Sugawara E; Nagano K; Nikaido H
    mBio; 2010 Oct; 1(4):. PubMed ID: 20978537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
    von Specht BU; Domdey H; Schödel F; Blum B; Lücking C; Knapp B; Muth G; Hungerer KD; Bröker M
    Behring Inst Mitt; 1994 Dec; (95):85-96. PubMed ID: 7538752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoinformatics design of multivalent chimeric vaccine for modulation of the immune system in Pseudomonas aeruginosa infection.
    Aminnezhad S; Abdi-Ali A; Ghazanfari T; Bandehpour M; Zarrabi M
    Infect Genet Evol; 2020 Nov; 85():104462. PubMed ID: 32682863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.
    Krause A; Whu WZ; Xu Y; Joh J; Crystal RG; Worgall S
    Vaccine; 2011 Mar; 29(11):2131-9. PubMed ID: 21215829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A hybrid outer membrane protein antigen for vaccination against Pseudomonas aeruginosa.
    Gabelsberger J; Knapp B; Bauersachs S; Enz UI; von Specht BU; Domdey H
    Behring Inst Mitt; 1997 Feb; (98):302-14. PubMed ID: 9382754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A computational approach to developing a multi-epitope vaccine for combating Pseudomonas aeruginosa-induced pneumonia and sepsis.
    Roy SK; Biswas MS; Foyzur Raman M; Hasan R; Rahmann Z; Uddin P K MM
    Brief Bioinform; 2024 Jul; 25(5):. PubMed ID: 39133098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reevaluation, using intact cells, of the exclusion limit and role of porin OprF in Pseudomonas aeruginosa outer membrane permeability.
    Bellido F; Martin NL; Siehnel RJ; Hancock RE
    J Bacteriol; 1992 Aug; 174(16):5196-203. PubMed ID: 1322882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative folding pathways of the major porin OprF of Pseudomonas aeruginosa.
    Sugawara E; Nagano K; Nikaido H
    FEBS J; 2012 Mar; 279(6):910-8. PubMed ID: 22240095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.
    Mansouri E; Gabelsberger J; Knapp B; Hundt E; Lenz U; Hungerer KD; Gilleland HE; Staczek J; Domdey H; von Specht BU
    Infect Immun; 1999 Mar; 67(3):1461-70. PubMed ID: 10024596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF.
    Worgall S; Krause A; Qiu J; Joh J; Hackett NR; Crystal RG
    J Virol; 2007 Dec; 81(24):13801-8. PubMed ID: 17942539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosa.
    Price BM; Barten Legutki J; Galloway DR; von Specht BU; Gilleland LB; Gilleland HE; Staczek J
    FEMS Immunol Med Microbiol; 2002 Jun; 33(2):89-99. PubMed ID: 12052563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy with IgY Antibodies toward Outer Membrane Protein F Protects Burned Mice against
    Norouzi F; Behrouz B; Ranjbar M; Mousavi Gargari SL
    J Immunol Res; 2020; 2020():7840631. PubMed ID: 32566689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conservation of surface epitopes in Pseudomonas aeruginosa outer membrane porin protein OprF.
    Martin NL; Rawling EG; Wong RS; Rosok M; Hancock RE
    FEMS Microbiol Lett; 1993 Nov; 113(3):261-6. PubMed ID: 7505760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenovirus-based vaccine with epitopes incorporated in novel fiber sites to induce protective immunity against Pseudomonas aeruginosa.
    Sharma A; Krause A; Xu Y; Sung B; Wu W; Worgall S
    PLoS One; 2013; 8(2):e56996. PubMed ID: 23437292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal vaccination with a recombinant OprF-I vaccine of Pseudomonas aeruginosa in healthy volunteers: comparison of a systemic vs. a mucosal booster schedule.
    Göcke K; Baumann U; Hagemann H; Gabelsberger J; Hahn H; Freihorst J; von Specht BU
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):167-71. PubMed ID: 12832121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of the major outer-membrane protein OprF from plant root-colonizing Pseudomonas fluorescens.
    De Mot R; Schoofs G; Roelandt A; Declerck P; Proost P; Van Damme J; Vanderleyden J
    Microbiology (Reading); 1994 Jun; 140 ( Pt 6)():1377-87. PubMed ID: 7521711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudomonas aeruginosa OprF plays a role in resistance to macrophage clearance during acute infection.
    Moussouni M; Berry L; Sipka T; Nguyen-Chi M; Blanc-Potard AB
    Sci Rep; 2021 Jan; 11(1):359. PubMed ID: 33432030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of OprF as a complement component C3 binding acceptor molecule on the surface of Pseudomonas aeruginosa.
    Mishra M; Ressler A; Schlesinger LS; Wozniak DJ
    Infect Immun; 2015 Aug; 83(8):3006-14. PubMed ID: 25964476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.